Literature DB >> 12663788

Interactions between papillomavirus L1 and L2 capsid proteins.

Renée L Finnen1, Kimberly D Erickson, Xiaojiang S Chen, Robert L Garcea.   

Abstract

The human papillomavirus (HPV) capsid consists of 360 copies of the major capsid protein, L1, arranged as 72 pentamers on a T=7 icosahedral lattice, with substoichiometric amounts of the minor capsid protein, L2. In order to understand the arrangement of L2 within the HPV virion, we have defined and biochemically characterized a domain of L2 that interacts with L1 pentamers. We utilized an in vivo binding assay involving the coexpression of recombinant HPV type 11 (HPV11) L1 and HPV11 glutathione S-transferase (GST) L2 fusion proteins in Escherichia coli. In this system, L1 forms pentamers, GST=L2 associates with these pentamers, and L1+L2 complexes are subsequently isolated by using the GST tag on L2. The stoichiometry of L1:L2 in purified L1+L2 complexes was 5:1, indicating that a single molecule of L2 interacts with an L1 pentamer. Coexpression of HPV11 L1 with deletion mutants of HPV11 L2 defined an L1-binding domain contained within amino acids 396 to 439 near the carboxy terminus of L2. L2 proteins from eight different human and animal papillomavirus serotypes were tested for their ability to interact with HPV11 L1. This analysis targeted a hydrophobic region within the L1-binding domain of L2 as critical for L1 binding. Introduction of negative charges into this hydrophobic region by site-directed mutagenesis disrupted L1 binding. L1-L2 interactions were not significantly disrupted by treatment with high salt concentrations (2 M NaCl), weak detergents, and urea concentrations of up to 2 M, further indicating that L1 binding by this domain is mediated by strong hydrophobic interactions. L1+L2 protein complexes were able to form virus-like particles in vitro at pH 5.2 and also at pH 6.8, a pH that is nonpermissive for assembly of L1 protein alone. Thus, L1/L2 interactions are primarily hydrophobic, encompass a relatively short stretch of amino acids, and have significant effects upon in vitro assembly.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663788      PMCID: PMC152166          DOI: 10.1128/jvi.77.8.4818-4826.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  The importance of being proline: the interaction of proline-rich motifs in signaling proteins with their cognate domains.

Authors:  B K Kay; M P Williamson; M Sudol
Journal:  FASEB J       Date:  2000-02       Impact factor: 5.191

2.  Preventing cervical cancer.

Authors:  J M Cain; M K Howett
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

Review 3.  Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report.

Authors:  J T Schiller; A Hidesheim
Journal:  J Clin Virol       Date:  2000-10       Impact factor: 3.168

4.  Structure of simian virus 40 at 3.8-A resolution.

Authors:  R C Liddington; Y Yan; J Moulai; R Sahli; T L Benjamin; S C Harrison
Journal:  Nature       Date:  1991-11-28       Impact factor: 49.962

5.  Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

Authors:  X S Chen; G Casini; S C Harrison; R L Garcea
Journal:  J Mol Biol       Date:  2001-03-16       Impact factor: 5.469

6.  Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.

Authors:  Y Kawana; K Kawana; H Yoshikawa; Y Taketani; K Yoshiike; T Kanda
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Gene transfer using recombinant rabbit hemorrhagic disease virus capsids with genetically modified DNA encapsidation capacity by addition of packaging sequences from the L1 or L2 protein of human papillomavirus type 16.

Authors:  S El Mehdaoui; A Touzé; S Laurent; P Y Sizaret; D Rasschaert; P Coursaget
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

8.  Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.

Authors:  C D Harro; Y Y Pang; R B Roden; A Hildesheim; Z Wang; M J Reynolds; T C Mast; R Robinson; B R Murphy; R A Karron; J Dillner; J T Schiller; D R Lowy
Journal:  J Natl Cancer Inst       Date:  2001-02-21       Impact factor: 13.506

9.  Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

Authors:  X S Chen; R L Garcea; I Goldberg; G Casini; S C Harrison
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

10.  L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.

Authors:  M M Okun; P M Day; H L Greenstone; F P Booy; D R Lowy; J T Schiller; R B Roden
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

View more
  55 in total

1.  Nuclear translocation of papillomavirus minor capsid protein L2 requires Hsc70.

Authors:  Luise Florin; Katrin A Becker; Cornelia Sapp; Carsten Lambert; Hüseyin Sirma; Martin Müller; Rolf E Streeck; Martin Sapp
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Subunit interactions in bovine papillomavirus.

Authors:  Matthias Wolf; Robert L Garcea; Nikolaus Grigorieff; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

Review 3.  Principles of polyoma- and papillomavirus uncoating.

Authors:  Carla Cerqueira; Mario Schelhaas
Journal:  Med Microbiol Immunol       Date:  2012-09-23       Impact factor: 3.402

Review 4.  The evolving field of human papillomavirus receptor research: a review of binding and entry.

Authors:  Adam B Raff; Andrew W Woodham; Laura M Raff; Joseph G Skeate; Lisa Yan; Diane M Da Silva; Mario Schelhaas; W Martin Kast
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

5.  Study of infectious virus production from HPV18/16 capsid chimeras.

Authors:  Horng-Shen Chen; Jennifer Bromberg-White; Michael J Conway; Samina Alam; Craig Meyers
Journal:  Virology       Date:  2010-07-03       Impact factor: 3.616

6.  Human Papillomavirus Major Capsid Protein L1 Remains Associated with the Incoming Viral Genome throughout the Entry Process.

Authors:  Stephen DiGiuseppe; Malgorzata Bienkowska-Haba; Lucile G M Guion; Timothy R Keiffer; Martin Sapp
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

7.  Surveying capsid assembly pathways through simulation-based data fitting.

Authors:  Lu Xie; Gregory R Smith; Xian Feng; Russell Schwartz
Journal:  Biophys J       Date:  2012-10-02       Impact factor: 4.033

8.  Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes.

Authors:  Samuel K Campos; Michelle A Ozbun
Journal:  PLoS One       Date:  2009-02-13       Impact factor: 3.240

9.  Target cell cyclophilins facilitate human papillomavirus type 16 infection.

Authors:  Malgorzata Bienkowska-Haba; Hetalkumar D Patel; Martin Sapp
Journal:  PLoS Pathog       Date:  2009-07-24       Impact factor: 6.823

Review 10.  Mechanisms of cell entry by human papillomaviruses: an overview.

Authors:  Caroline A J Horvath; Gaëlle A V Boulet; Virginie M Renoux; Philippe O Delvenne; John-Paul J Bogers
Journal:  Virol J       Date:  2010-01-20       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.